Since abnormal lipid metabolism is essential for the activity of cancer stem cell maintenance 26, 27, we assumed that the activation of the LPL/FABP4/CPT1 metabolic axis may be an important promoter to facilitate the progression of NASH to HCC through collaboration with oncogenic signals. The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatohepatitis.